Physician profile
Anthony Visioni
NPI 1982867636
$1,322.15
in general payments reported to CMS, 2019-2025
16 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.46 · 2022: $453 · 2023: $146 · 2024: $264 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $783.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $376.47 | 2022-2023 | Da Vinci Surgical System |
| Dilon Technologies, INC. | $191.03 | 2023-2025 | Hemoblast Bellows |
| Polynovo North America LLC | $137.86 | 2024 | Novosorb Btm |
| E.R. Squibb & Sons, L.L.C. | $115.91 | 2022 | |
| Medtronic, INC. | $85.86 | 2025 | Signia |
| Angiodynamics, INC. | $71.51 | 2019 | |
| Abbvie INC. | $63.49 | 2024-2025 | |
| Boston Scientific Corporation | $59.56 | 2023-2024 | Spyglass Discover, Spyglass |
| Foundation Medicine, INC. | $55.78 | 2023 | |
| Glaxosmithkline, LLC. | $30.97 | 2024 | Jemperli, Zejula |
| Tempus Ai, INC | $27.67 | 2025 | Xt Cdx |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $26.87 | 2025 | |
| Eisai INC. | $24.99 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $23.12 | 2025 | |
| Vivus LLC | $17.11 | 2023 | Qsymia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Visioni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.